El establecimiento del centro demuestra el compromiso de la empresa de ofrecer soluciones diferenciadas a los desafíos de ginecología y pediatría SHANGHÁI, 26 de diciembre de 2023 /PRNewswire/ — Changchun GeneScience Pharmaceutical (“GenSci”), una filial de Changchun High-Tech Industries…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.